| |
| |
|
| Insider
Information: |
Gupta Suneel |
| Relationship: |
Chief Development Offi... |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
183,285 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,427,069 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
183,285 |
|
|
| Total
Value |
$5,427,069 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protagonist Therapeutics, Inc |
PTGX |
Chief Development Offi... |
2024-02-26 |
183,285 |
2019-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2024-02-26 |
4 |
D |
$29.53 |
$126,447 |
D/D |
(4,282) |
183,285 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2024-01-09 |
4 |
AS |
$25.00 |
$125,000 |
D/D |
(5,000) |
187,567 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2024-01-09 |
4 |
OE |
$7.38 |
$36,900 |
D/D |
5,000 |
192,567 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
19,250 |
187,567 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2023-10-19 |
4 |
OE |
$7.38 |
$147,600 |
D/D |
20,000 |
168,317 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2023-05-31 |
4 |
D |
$26.07 |
$108,191 |
D/D |
(4,150) |
148,037 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
152,187 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2023-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,625 |
138,187 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2022-04-26 |
4 |
OE |
$7.38 |
$295,200 |
D/D |
40,000 |
117,561 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2022-02-28 |
4 |
D |
$24.28 |
$15,758 |
D/D |
(649) |
77,007 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
77,656 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Development Officer |
• – – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
63,987 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
EVP Clinical Operations |
• – – |
2019-12-03 |
4 |
B |
$5.13 |
$153,900 |
D/D |
30,000 |
49,500 |
2.74 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
EVP Clinical Operations |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
17,500 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
